Bringing Innovative Solutions to Healthcare Practitioners.
Bringing Innovative Solutions to Healthcare Practitioners.
Bringing Innovative Solutions to Healthcare Practitioners.
A Focus on Neurology
Since Moleac was founded, our ambition is to provide new solutions to supplement the therapeutic armamentarium for conditions where significant unmet needs remain. To achieve this goal, we develop natural products according to international standards and commercialize our products worldwide.
Our products are developed by Moleac with scientific excellence and evidence-based approach.
Together with our R&D department and world renowned experts, we have successfully developed and marketed NeuroAiD, the world’s first post-stroke recovery treatment, helping patients to regain functional independence after a stroke or a traumatic brain injury by amplifying endogenous processes of brain repair. NeuroAiD is available in over 30 countries worldwide.
Challenging the Boundaries to The Possible.
OUR INNOVATION TO RECONNECT AFTER A BRAIN INJURY
NeuroAiD is an oral treatment helping patients of brain and spinal cord injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapy and exercises. NeuroAiD also supports cognitive functions in Alzheimer’s Disease.
IMPROVING COGNITION AND DAILY FUNCTIONING IN VASCULAR DEMENTIA
Made of 3 natural ingredients, CognivAiD is an innovative therapeutic approach for the treatment of Vascular Dementia.
Patients taking NeuroAid yearly
Awards
Countries with Exclusive Partnership
Let’s talk about moleac with noemie & david picard
Moleac in a nutshell. Noemie, 9 years old, gets to know more about Moleac with David Picard, its co-founder and CEO.
Latest News
Exploring Breakthroughs in Alzheimer’s Treatment: An Interview with Prof Christopher Chen on the ATHENE Trial
Supporting Innovation: Sponsoring the Inaugural ISRRA Think Tank at the 13th World Congress for NeuroRehabilitation
Proud to have sponsored and supported the first ISRRA Think Tank in Vancouver last May..
Discover the Impact of NeuroAiD on Stroke Recovery: Insights from Dr. N Venketasubramanian
Reflecting on the Successful Baku Neurology Gathering: A Collaborative Summit on Neurological Advancements
Last month, we had the privilege of hosting a remarkable event in Baku, gathering esteemed neurologists from Turkey, Azerbaijan, Uzbekistan, and Kazakhstan.
Alzheimer’s Disease Clinical Study Highlights: Enhancing Decision-Making with ‘Time Saved’ Calculations
🌟 Success at ESOC Basel: Symposium on Innovative Neurorehabilitation Approaches
ASAP’s 52nd Meeting at ESOC 2024: Welcoming New Members and Celebrating Achievements in Stroke Research
The Asian Stroke Advisory Panel (ASAP) held its 52ⁿᵈ meeting in Basel, alongside ESOC 2024.
Visit Moleac at ESOC 2024: Explore Our Innovative Stroke Treatments at Booth B8
We are at the European Stroke Organisation Conference in Basel!
Raising Awareness During Dementia Awareness Week: Understanding and Managing Alzheimer’s Disease
Dementia Awareness Week! According to the World Health Organization, over 55 million people suffer from dementia worldwide.
